Healthcare -
Biotechnology - NASDAQ - US
$ 15.04
-3.16 %
$ 1.19 B
Market Cap
-3.48
P/E
VRDN - OTHER CURRENT ASSETS
Other Current Assets VRDN - Viridian Therapeutics, Inc.
9.01 M
LAST VALUE
84.45%
2 YEAR CAGR
11.48%
5 YEAR CAGR
33.66%
10 YEAR CAGR